|
Market Closed -
Toronto S.E.
20:59:34 19/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 9.180 CAD | -0.76% |
|
-14.29% | +15.91% |
| 10-05 | Satellos Bioscience Granted Composition of Matter Patent for Forazapadin by USPTO | MT |
| 10-05 | Satellos Bioscience Receives US Patent for Forazapadin | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.76% | -14.29% | -29.55% | -25.31% | +15.91% | -4.38% | +91.25% | -47.60% | - | 138M | |
| +1.52% | -7.19% | -8.44% | +24.27% | +61.63% | +51.66% | +69.99% | +1.03% | - | 65.83B | |
| +0.07% | +8.37% | +11.84% | +8.64% | +14.13% | +10.99% | +84.38% | -16.47% | +231.60% | 51.87B | |
| +1.92% | +3.51% | -14.31% | -1.30% | +3.77% | +1.89% | +64.09% | +192.26% | +4,998.01% | 51.2B | |
| -0.38% | +1.40% | -0.20% | +28.91% | +17.95% | +29.98% | +42.37% | +6.77% | +253.52% | 43.76B | |
| +0.30% | +5.64% | +5.51% | +18.64% | +21.84% | +16.99% | +133.30% | -1.55% | +1,027.54% | 42.09B | |
| +2.35% | -6.08% | -4.61% | -2.15% | +128.69% | +236.69% | +528.10% | +562.85% | - | 39.04B | |
| +2.16% | +9.87% | +10.48% | +12.74% | +14.98% | +18.92% | +59.70% | +10.58% | +163.35% | 34B | |
| +3.84% | -2.34% | -5.57% | +30.82% | +59.19% | +39.18% | +8.57% | -57.11% | - | 25.2B | |
| +0.43% | +3.56% | +13.19% | +38.49% | +26.20% | +28.77% | +23.93% | -12.64% | +121.28% | 22.8B | |
| +1.71% | -6.92% | -7.13% | -2.48% | -6.29% | -15.15% | -4.32% | -66.06% | - | 22.41B | |
| -1.02% | -3.32% | -20.59% | -12.03% | -45.25% | -42.51% | +277.69% | +257.70% | +599.12% | 20.81B | |
| +0.19% | -0.06% | +1.20% | +15.24% | +10.33% | +17.34% | +169.93% | +233.74% | +1,913.19% | 17.3B | |
| -5.62% | -0.84% | -0.42% | -1.67% | +177.32% | +152.60% | +367.34% | +1,438.75% | +717.19% | 14.99B | |
| +0.72% | +4.78% | +7.40% | +12.09% | +43.01% | +59.69% | +200.91% | +191.53% | +444.10% | 15.53B | |
| -0.30% | +0.31% | +0.82% | +10.69% | +26.12% | +23.16% | +71.12% | -29.72% | +86.10% | 15.37B | |
| +2.09% | +1.30% | -2.86% | -11.90% | - | - | - | - | - | 15.1B | |
| -0.04% | -0.61% | +7.90% | +33.73% | +50.40% | +68.06% | +60.10% | -27.27% | +272.33% | 14.32B | |
| +3.54% | +4.00% | -5.57% | -7.14% | +19.33% | -2.34% | +545.07% | - | - | 13.77B | |
| -1.20% | +2.27% | +2.46% | -1.09% | -7.73% | -9.14% | -25.45% | -39.43% | +114.33% | 12.97B | |
| Average | +0.57% | -0.51% | -1.92% | +8.46% | +33.24% | +35.92% | +145.69% | +144.30% | +841.67% | 26.93B | |
| Weighted average by Cap. | +0.88% | +0.04% | -1.00% | +12.08% | +34.44% | +40.30% | +132.83% | +119.68% | +1,121.76% |
- Stock Market
- Stocks
- MSCL Stock
- Sector Satellos Bioscience Inc.
Select your edition
All financial news and data tailored to specific country editions
